House E&C Committee Calls On FTC to Review PBM Mergers

The House Energy & Commerce Committee has called on the Federal Trade Commission to “closely analyze” recent mergers by pharmacy benefit managers to assess the impact on prescription drug prices.
Source: Drug Industry Daily